Literature DB >> 9415567

Acute respiratory failure and pulmonary fibrosis secondary to administration of mycophenolate mofetil.

D C Gross1, T M Sasaki, M K Buick, J A Light.   

Abstract

BACKGROUND: We report the first documented case of pulmonary toxicity to mycophenolate mofetil in this article.
METHODS: A 51-year-old woman experienced systemic reactions beginning 10 days after cadaveric renal transplantation.
RESULTS: Recurrent respiratory failure and documented progressive pulmonary fibrosis ensued. Cultures were negative and other agents were discontinued. It was not until the mycophenolate was stopped did the patient improve.
CONCLUSIONS: Mycophenolate mofetil can cause acute respiratory failure simulating opportunistic infection or pulmonary edema. If not recognized, this may lead to the rapid development of severe pulmonary fibrosis, some of which may not be reversible.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9415567     DOI: 10.1097/00007890-199712150-00020

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

Review 1.  Benefit-risk assessment of sirolimus in renal transplantation.

Authors:  Dirk R J Kuypers
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  Acute respiratory failure during first cyclophosphamide infusion in a patient with systemic lupus erythematosus.

Authors:  P Schjelderup; T C El-Galaly; J B Frøkjær; T Ring
Journal:  Z Rheumatol       Date:  2014-12       Impact factor: 1.372

3.  Unusual Case of Acute Lung Injury in a Renal Allograft Recipient.

Authors:  U Anandh; S Marda
Journal:  Indian J Nephrol       Date:  2017 May-Jun

4.  Mycophenolate Mofetil and Pulmonary Fibrosis After Kidney Transplantation: A Case Report.

Authors:  Kazuhiro Takahashi; Pauline Go; Chad H Stone; Mohamed Safwan; Krishna G Putchakayala; William J Kane; Lauren E Malinzak; Dean Y Kim; Jason E Denny
Journal:  Am J Case Rep       Date:  2017-04-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.